ebselen and N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide

ebselen has been researched along with N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	6 (100.00)	2.80

Authors

Authors	Studies
Bai, F; Deng, Y; Du, X; Duan, Y; Guddat, LW; Jiang, H; Jiang, R; Jin, Z; Li, X; Liu, F; Liu, H; Liu, M; Liu, X; Peng, C; Qin, C; Rao, Z; Shi, Z; Wang, L; Xiao, G; Xu, W; Xu, Y; Yang, H; Yang, K; Yang, X; You, T; Yu, J; Zhang, B; Zhang, L; Zhao, Y	1
Anderson, L; Bassi, ÊJ; Cardoso, SH; da Silva Santos-Júnior, PF; da Silva-Júnior, EF; de Andrade Brandão, J; Silva, LR; Xavier de Araújo-Júnior, J	1
Beccari, AR; Cannalire, R; Cerchia, C; Di Leva, FS; Summa, V	1
Barreiro, EJ; Franco, LS; Maia, RC	1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW	1
Dou, X; Guo, Z; Huo, T; Jiao, N; Lai, L; Liu, Y; Liu, Z; Lu, Y; Song, S; Su, L; Sun, Q; Wang, B; Wang, C; Xu, G; Yu, Z; Zhang, C; Zhang, L; Zhao, X	1

Reviews

2 review(s) available for ebselen and N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide

Article	Year
Druggable targets from coronaviruses for designing new antiviral drugs. Bioorganic & medicinal chemistry, 2020, 11-15, Volume: 28, Issue:22 Topics: Animals; Antiviral Agents; Drug Design; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2	2020
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities. Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4 Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Structure; Protease Inhibitors; RNA-Dependent RNA Polymerase; SARS-CoV-2	2022

Other Studies

4 other study(ies) available for ebselen and N-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N-{(2S,3E)-5-(benzyloxy)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl}-L-leucinamide

Article	Year
Structure of M Nature, 2020, Volume: 582, Issue:7811 Topics: Antiviral Agents; Betacoronavirus; Cells, Cultured; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Humans; Models, Molecular; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein Structure, Tertiary; SARS-CoV-2; Viral Nonstructural Proteins	2020
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (M RSC medicinal chemistry, 2021, Jan-01, Volume: 12, Issue:1 Topics:	2021
Perspectives on SARS-CoV-2 Main Protease Inhibitors. Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23 Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors	2021
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease. European journal of medicinal chemistry, 2022, Aug-05, Volume: 238 Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Drug Discovery; Furans; Humans; Hydrazines; Molecular Docking Simulation; Protease Inhibitors; SARS-CoV-2	2022